concord-drugs-ltd
Home
Concord Drugs Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹36.87 Cr
Concord Drugs Ltd Performance
▲
▲
▲
▲
Concord Drugs Ltd Fundamentals
Concord Drugs Ltd Delivery and Volume
About Concord Drugs Ltd
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready
| Name | Designation |
|---|---|
| S Nagi Reddy | Chairman & Managing Director |
| K Ramchandra Reddy | Independent Director |
| Koni Reddy | Whole Time Director & CFO |
| S. Nagavenkata Hareesh | Independent Director |
| S. Manoj Kumar Reddy | Whole-time Director |
| Summela Kasu | Independent Director |
| Namratha Nagla | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Concord Drugs Ltd FAQs
How do I Buy Concord Drugs Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Concord Drugs Ltd shares in BlinkX.
What is the Share Price of Concord Drugs Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Concord Drugs Ltd's share price is ₹36.4 as of 2024-12-12.
What is the PE ratio of Concord Drugs Ltd?
Concord Drugs Ltd's P/E ratio is - times as of 2024-12-12.
What is the PB ratio of Concord Drugs Ltd?
Concord Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 1.09, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Concord Drugs Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Concord Drugs Ltd's market capitalization is ₹36.87 Cr as on 2024-12-12.
What is the ROE of Concord Drugs Ltd?
The current financial records of Concord Drugs Ltd show a 1.28% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Concord Drugs Ltd?
According to Concord Drugs Ltd's most recent financial filings, the company has a total asset value of ₹41.38, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Concord Drugs Ltd?
The 52-week high/low price of a Concord Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Concord Drugs Ltd's 52-week high and low as of 2024-12-12 are ₹38.84 and ₹36.26, respectively.
